These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29157782)

  • 1. Comparative Assessment of the Effect of Hyper-glycosylation on the Pattern and Kinetics of Degradation of Darbepoetin Alfa using a Stability-Indicating Orthogonal Testing Protocol.
    Moenes EM; Al-Ghobashy MA; Mohamed AA; Salem MY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():405-414. PubMed ID: 29157782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the pattern and kinetics of degradation of adalimumab using a stability-indicating orthogonal testing protocol.
    Hassan LA; Al-Ghobashy MA; Abbas SS
    Biomed Chromatogr; 2019 Dec; 33(12):e4676. PubMed ID: 31389037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the combined effects of pegylation and glycosylation on the stability of erythropoietin using a stability-indicating SE-HPLC.
    Abed HS; Al-Ghobashy MA; Fathalla FA; Salem MY
    Biologicals; 2017 Nov; 50():129-136. PubMed ID: 28958787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability assessment of antibody-drug conjugate Trastuzumab emtansine in comparison to parent monoclonal antibody using orthogonal testing protocol.
    Mohamed HE; Mohamed AA; Al-Ghobashy MA; Fathalla FA; Abbas SS
    J Pharm Biomed Anal; 2018 Feb; 150():268-277. PubMed ID: 29258046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical comparability study of anti-CD20 monoclonal antibodies rituximab and obinutuzumab using a stability-indicating orthogonal testing protocol: Effect of structural optimization and glycoengineering.
    Trabik YA; Moenes EM; Al-Ghobashy MA; Nebsen M; Ayad MF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1159():122359. PubMed ID: 32920338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Physicochemical and Biological Characterization of the Proposed Biosimilar Darbepoetin Alfa, LBDE, and Its Originator Darbepoetin Alfa, NESP
    Jeong YR; Jeong RU; Son JH; Kwon JC; Jung S; Song MA; Hwang JA; Lee GM
    BioDrugs; 2018 Apr; 32(2):153-168. PubMed ID: 29556960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive stability assessment of insulin degludec using New customized validated RP-HPLC and SEC-HPLC methods in an orthogonal testing protocol.
    Abdelwaly EA; Mohamed AA; El-Kosasy AM; Ayad MF
    J Pharm Biomed Anal; 2021 Sep; 203():114175. PubMed ID: 34098506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH dependent effect of glycosylation on protein stability.
    Wang W; Antonsen K; Wang YJ; Wang DQ
    Eur J Pharm Sci; 2008 Feb; 33(2):120-7. PubMed ID: 18162379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric characterisation of darbepoetin alfa biosimilars with C-terminal arginine residues.
    Okano M; Sato M; Kageyama S
    Drug Test Anal; 2016 Nov; 8(11-12):1138-1146. PubMed ID: 27706921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the long-acting erythropoiesis-stimulating agent darbepoetin alfa in human urine by liquid chromatography-tandem mass spectrometry.
    Okano M; Sato M; Kageyama S
    Anal Bioanal Chem; 2014 Feb; 406(5):1317-29. PubMed ID: 23443522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical and biological evaluation of JR-131 as a biosimilar to a long-acting erythropoiesis-stimulating agent darbepoetin alfa.
    Tani J; Ito Y; Tatemichi S; Yamakami M; Fukui T; Hatano Y; Kakimoto S; Kotani A; Sugimura A; Mihara K; Yamamoto R; Tanaka N; Minami K; Takahashi K; Hirato T
    PLoS One; 2020; 15(4):e0231830. PubMed ID: 32302352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability assessment of FDA-approved ramucirumab monoclonal antibody; validated SE-HPLC method for degradation pattern evaluation.
    Abdelghaffar SH; Hegazy MA; Eltanany BM
    Biomed Chromatogr; 2022 Feb; 36(2):e5258. PubMed ID: 34622957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between Dynamic Light Scattering and Size Exclusion High Performance Liquid Chromatography for Monitoring the Effect of pH on Stability of Biopharmaceuticals.
    Al-Ghobashy MA; Mostafa MM; Abed HS; Fathalla FA; Salem MY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():1-9. PubMed ID: 28578190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric glycoform profiling of the innovator and biosimilar erythropoietin and darbepoetin by LC/ESI-MS.
    Harazono A; Hashii N; Kuribayashi R; Nakazawa S; Kawasaki N
    J Pharm Biomed Anal; 2013 Sep; 83():65-74. PubMed ID: 23708432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and expression of codon-optimized recombinant darbepoetin alfa in Leishmania tarentolae T7-TR.
    Kianmehr A; Golavar R; Rouintan M; Mahrooz A; Fard-Esfahani P; Oladnabi M; Khajeniazi S; Mostafavi SS; Omidinia E
    Protein Expr Purif; 2016 Feb; 118():120-5. PubMed ID: 26546410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of ricobendazole in aqueous solutions.
    Wu Z; Tucker IG; Razzak M; Medlicott NJ
    J Pharm Biomed Anal; 2009 Jul; 49(5):1282-6. PubMed ID: 19342190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a stability indicating RP-HPLC method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution.
    Kasawar GB; Farooqui M
    J Pharm Biomed Anal; 2010 May; 52(1):19-29. PubMed ID: 20045275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of weekly darbepoetin alfa in the treatment of anaemia of HIV-infected haemodialysis patients.
    Lucas C; Carrera F; Jorge C; Boquinhas H; Pais MJ
    Nephrol Dial Transplant; 2006 Nov; 21(11):3202-6. PubMed ID: 16891651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epoetin alfa and darbepoetin alfa: effects on ventricular hypertrophy in patients with chronic kidney disease.
    Chen HH; Tarng DC; Lee KF; Wu CY; Chen YC
    J Nephrol; 2008; 21(4):543-9. PubMed ID: 18651544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screen and confirmation of PEG-epoetin β in equine plasma.
    Chang Y; Maylin GM; Matsumoto G; Neades SM; Catlin DH
    Drug Test Anal; 2011 Jan; 3(1):68-73. PubMed ID: 21254454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.